New tatt? We're ok with that! Relaxing the tattoo deferral for plasmapheresis donors maintains safety and increases donations

Claire E. Styles,Veronica C. Hoad,Robert Harley,John Kaldor,Iain B. Gosbell
DOI: https://doi.org/10.1111/vox.13704
2024-06-27
Vox Sanguinis
Abstract:Background and Objectives Tattooing is one of the leading donor deferral reasons in Australia. Until September 2020, donors were deferred from all donation types for 4 months after a tattoo. At this time, our guideline changed such that donations of plasma for further manufacture were accepted immediately, provided the tattoo was administered in a licensed or regulated Australian establishment. We examined the effects of this change. Materials and Methods Donors with a tattoo deferral in the 2 years before or after the guideline change were identified and followed up until 3 November 2022. Between the two periods, we compared blood‐borne virus (BBV) incidence, donor return, and the number of donors and donations regained after deferral. Results The incidence of BBV infection in donors after a tattoo deferral was zero in both periods. To exceed a residual risk of 1 in 1 million for hepatitis C virus, 190 donors would need to be infected yearly from a tattoo. Donors returned to donate significantly faster after the change (median return 85 days compared with 278 days). An extra 187 donations per 10,000 person‐years of observation were gained, yielding a total of 44,674 additional plasma donations nationally 0–4 months after getting a tattoo. Conclusion Allowing plasma donations immediately post‐tattoo resulted in a substantial donation gain with no adverse safety effect. Lifeblood subsequently reduced the deferral for transfusible component donations to 7 days for tattoos in Australian licensed/regulated establishments.
hematology
What problem does this paper attempt to address?